Genetic testing and health technology company Prenetics Global Limited (Nasdaq: PRE) has announced the purchase of $20 million worth of Bitcoin as part of a strategy to diversify its corporate treasury. The acquisition, totaling approximately 187.42 BTC at an average price of $106,700, reflects the company’s shift away from traditional currencies and toward crypto assets as a reserve vehicle. Following the announcement, Prenetics shares surged significantly on the market.
A Signal of Corporate Transformation: Prenetics’ $20M Bitcoin Move
Operating in the health-tech sector, Prenetics continues to draw attention not only for its services but also for its bold financial strategies. The company’s Bitcoin acquisition marks a break from conventional treasury management and highlights a growing embrace of digital assets.
Historically known for its genomic testing solutions, Prenetics has now become one of the first health-tech firms to integrate crypto into its balance sheet. Investors reacted positively, with the stock price jumping nearly 20% after the announcement.
This isn’t the company’s first high-profile move. During its IPO process, Prenetics drew attention by securing investment from football legend David Beckham. Now, it is reinforcing its public visibility by entering the world of crypto finance.
Treasury Policy Rewritten: A Bitcoin-Focused Balance Sheet
Prenetics’ Bitcoin purchase goes beyond a short-term trade, signaling a fundamental restructuring of its financial framework. With board approval, the company has committed to holding a portion of its reserves in Bitcoin rather than fiat currencies — the first step toward building a “digital asset–weighted” balance sheet.
In its statement, Prenetics stressed that this approach is not only about asset diversification but also about long-term value preservation. Citing Bitcoin’s resilience against inflation, the company sees this move as a potential strategic advantage over time. The purchase was executed via institutional exchange Kraken, which will also provide custody solutions.
With $117 million in liquid assets and $66 million in cash reserves, the $20 million Bitcoin acquisition represents a meaningful allocation. Prenetics’ debt-free balance sheet further enabled this strategic shift.
From Genomics to Blockchain: Signs of a Broader Vision
The Bitcoin investment also reflects Prenetics’ expanding corporate vision. CEO Danny Yeung emphasized the potential intersection of health technologies and blockchain, envisioning a future where individuals maintain greater control over their genetic data and privacy through decentralized systems.
Concrete steps are already in motion. On platforms like CircleDNA and IM8 Health, Prenetics plans to enable crypto-based payments in the near future. The company is also exploring ways to integrate Bitcoin and other digital assets into data security and sharing infrastructures for personal health records.
Supporting this vision is a team of seasoned advisors from the crypto and Web3 sectors. These include Andy Cheung, former COO of OKEx, as well as Tracy Hoyos López and Raphael Strauch, both with extensive experience in digital asset consulting. This makes clear that Prenetics’ strategy extends far beyond a single Bitcoin purchase.
Market Response: Stock Surge Signals Renewed Confidence
Investor reaction was swift. Prenetics’ stock price surged nearly 23% intraday after the announcement — a significant turnaround for a company that had lost over 90% of its market value since IPO.
This rally indicates that investors interpret the Bitcoin purchase as a strategic transformation, particularly notable in the health sector, where corporate Bitcoin allocations remain rare.
Analysts highlighted that the move strengthens not only the company’s balance sheet but also its brand perception and investor trust. Many expect further Bitcoin-related initiatives or crypto-integrated products to sustain this positive momentum.
What Does Bitcoin Adoption by Health-Tech Firms Mean?
Prenetics’ Bitcoin investment is not just about its internal strategy — it also signals a new chapter for corporate adoption of digital assets. Traditionally led by tech and software companies, institutional crypto adoption is now expanding into sectors like healthcare.
For investors, this sends an important message: as corporate acceptance broadens, confidence in Bitcoin as more than a speculative asset grows. If even conservative sectors begin treating Bitcoin as a reserve asset, its long-term legitimacy strengthens.
Still, experts caution that such moves also carry risks. While corporate adoption creates opportunity, regulatory uncertainty and market volatility remain key challenges.
Ultimately, the Prenetics case shatters the perception that “crypto is only for tech firms.” This shift could reshape decision-making for both individual investors and traditional market participants alike.
